MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock, net of...
$266K
Net cash provided by
financing activities
$210K
Effect of exchange rate
on cash and cash...
$127K
Canceled cashflow
$56K
Net (decrease)
increase in cash and cash...
-$474K
Canceled cashflow
$337K
Accounts receivable, net
-$340K
Accounts payable
$229K
Operating lease
liabilities
$162K
Withholding tax payable
$109K
Deferred income taxes
-$107K
Accrued expenses and
other current...
$78K
Deferred consideration,
net of discount
$62K
Depreciation
$34K
Stock-based compensation
$24K
Principal payments on
short-term debt
$56K
Net cash (used in)
provided by operating...
-$764K
Canceled cashflow
$1,145K
Net cash used in
investing activities
-$47K
Net loss
-$819K
Deferred revenue
-$449K
Prepaid expenses and
other current assets
$392K
Operating lease
right-of-use asset
$161K
something is missing
-$48K
Inventories, net
$40K
Purchases of property and
equipment
$47K
Back
Back
Cash Flow
source: myfinsight.com
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)